Lineage Cell Therapeutics (LCTX) Non-Current Assets (2010 - 2026)
Lineage Cell Therapeutics (LCTX) posted Non-Current Assets of $53.25 million for Q2 2026, up 13.4% from $46.96 million a year earlier but down 0.2% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Lineage Cell Therapeutics' Non-Current Assets came in at $53.43 million, down 14.1% from FY2024.
- Annual Non-Current Assets has declined for three consecutive years, with a five-year compound annual growth rate of -3.5% (FY2020 to FY2025).
- In prior years, Lineage Cell Therapeutics' Non-Current Assets was $62.22 million in FY2024 (-0.6%), $62.58 million in FY2023 (-1.7%), $63.66 million in FY2022 (+1.1%) and $63 million in FY2021 (-1.5%).
- Quarterly Non-Current Assets has run from a low of $46.96 million in Q2 2025 to a high of $63.66 million in Q4 2022 over five years.
- On a year-over-year basis, Non-Current Assets increased in 1 of the last eight quarters, with an average decline of 8.2%.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q2 2026, with growth of 13.4%; the weakest was Q2 2025, with a decline of 24.8%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $53.37 million (Q1 2026), $53.43 million (Q4 2025) and $47.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | 53.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.25 Mn |
| Mar 31, 2026 | 53.37 Mn |
| Dec 31, 2025 | 53.43 Mn |
| Sep 30, 2025 | 47.38 Mn |
| Jun 30, 2025 | 46.96 Mn |
| Mar 31, 2025 | 61.77 Mn |
| Dec 31, 2024 | 62.22 Mn |
| Sep 30, 2024 | 62.19 Mn |
| Jun 30, 2024 | 62.41 Mn |
| Mar 31, 2024 | 62.77 Mn |
| Dec 31, 2023 | 62.58 Mn |
| Sep 30, 2023 | 62.67 Mn |
| Jun 30, 2023 | 63.20 Mn |
| Mar 31, 2023 | 63.55 Mn |
| Dec 31, 2022 | 63.66 Mn |
| Sep 30, 2022 | 62.64 Mn |
| Jun 30, 2022 | 61.90 Mn |
| Mar 31, 2022 | 62.65 Mn |
| Dec 31, 2021 | 63.00 Mn |
| Sep 30, 2021 | 62.87 Mn |
API Access
Lineage Cell Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();